New Ray Medicine International Holding Limited

Greenhouse gas emissions & sustainability report data

๐Ÿ“Š Latest report period: 2018๐Ÿ—‚๏ธ Report periods on file: 2018

In its 2018 reporting, New Ray Medicine International Holding Limited disclosed greenhouse gas emissions of 155.7 tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

๐Ÿ’จ
GHG Emissions
155.7 tCO2e/year
2018
๐Ÿ’ง
Water Usage
1.2K m3/year
2018
โ™ป๏ธ
Waste
9.2 tons/year (packaging materials, paper)
2018
โš™๏ธ
Energy Use
137.3K kWh/year
2018

โœ… Reported Environmental Achievements

๐ŸŽฏ Climate & Sustainability Targets

๐Ÿ”œ Short-term

  • Continue to enhance product portfolio, distribution channels, and marketing and promotion strategy.

๐Ÿ“… Medium-term

  • Continue to enhance and expand sales and marketing capabilities.
  • Explore opportunities to enhance distribution capabilities.
  • Seek potential merger and acquisition opportunities in medical-related industries.

๐Ÿ”ญ Long-term

  • Become a national leading pharmaceutical distributor.

๐ŸŒฑ ESG Focus Areas

EnvironmentalSocialGovernance

โš ๏ธ Challenges & Risks +

  • Challenges in the pharmaceutical industry due to government policies such as the โ€œ4+7 centralised purchase policyโ€ and the โ€œTwo-Invoiceโ€ System, leading to price cuts and lower profit margins.
  • Competition with national leading pharmaceutical distribution companies due to the โ€œTwo-Invoiceโ€ System.
  • Drug pricing pressure and loss of market share due to the โ€œ4+7 centralised purchase policyโ€.
  • Suspension of trading in shares due to concerns about materially false, incomplete, or misleading information in company announcements.

๐Ÿ“‹ Report Information

Reporting Period: 2018
Frameworks: HKEx ESG Reporting Guide